Quantum Surgical announced today that it received FDA 510(k) clearance for its Epione interventional oncology robotics platform. Montpellier, France–based Quantum Surgical designed Epione, a robot-assisted system, to plan, target, deliver and confirm tumor ablation in minimally invasive liver cancer treatment. Get the full story at our sister site, MassDevice.
The post FDA clears Quantum Surgical’s robot-assisted tumor ablation tech appeared first on Medical Design and Outsourcing.
Original Article: (https://www.medicaldesignandoutsourcing.com/fda-clears-quantum-surgicals-robot-assisted-tumor-ablation-tech/)
